Efficacy and safety of TAS-116, an oral inhibitor of heat...

Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial

Doi, Toshihiko, Kurokawa, Yukinori, Sawaki, Akira, Komatsu, Yoshito, Ozaka, Masato, Takahashi, Tsuyoshi, Naito, Yoichi, Ohkubo, Shuichi, Nishida, Toshirou
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
121
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2019.08.009
Date:
November, 2019
File:
PDF, 1.32 MB
english, 2019
Conversion to is in progress
Conversion to is failed